Hudock, Inc. has filed a Form 13F-HR with the Securities and Exchange Commission, disclosing its equity securities holdings as of the close of business on September 30, 2026. The filing, signed by President Michael J. Hudock, Jr., details the firm's portfolio of public equity investments.
The report lists a total of 225 individual equity securities held by Hudock, Inc. The top holding in the portfolio is Apple Inc., which the firm holds 33,859 shares. Berkshire Hathaway Inc. Class B shares follow with 28,999 shares, while Chevron Corporation is held in the third position with 20,243 shares.
The filing also details significant positions in several exchange-traded funds (ETFs) and technology companies. The firm holds 12,586 shares of the iShares Core S&P 500 ETF and 12,081 shares of Microsoft Corporation. Other notable positions include JPMorgan Chase & Co. (20,809 shares), Eli Lilly & Co. (3,062 shares), and Procter & Gamble Co. (19,372 shares).
The portfolio is diversified across various sectors, including healthcare, energy, finance, and technology. Notable healthcare holdings include Johnson & Johnson (13,115 shares) and Merck & Co. (31,114 shares). Energy positions include ExxonMobil Holdings Corp. (41,061 shares) and Valero Energy Corp. (1,119 shares). The filing indicates that all positions are held in a sole voting capacity.
